Market Overview

Celgene Reports Prelim. Q4 Adj. EPS $1.51 Including $0.10/Share Negative Effect vs $1.55 Est.

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News Guidance

 

Related Articles (CELG)